137 related articles for article (PubMed ID: 27545301)
1. Robust neuroprotective effects of 2-((2-oxopropanoyl)oxy)-4-(trifluoromethyl)benzoic acid (OPTBA), a HTB/pyruvate ester, in the postischemic rat brain.
Kim SW; Lee HK; Kim ID; Lee H; Luo L; Park JY; Yoon SH; Lee JK
Sci Rep; 2016 Aug; 6():31843. PubMed ID: 27545301
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effect of triflusal and its main metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid (HTB), in the postischemic brain.
Kim SW; Choi KJ; Park JY; Yoon SH; Lee JK
Neurosci Lett; 2017 Mar; 643():59-64. PubMed ID: 28189746
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effects of OBA-09, a salicylic acid/pyruvate ester, in the postischemic brain.
Lee HK; Kim SW; Jin Y; Kim ID; Park JY; Yoon SH; Lee JK
Brain Res; 2013 Aug; 1528():68-79. PubMed ID: 23850644
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory and anti-excitoxic effects of diethyl oxopropanamide, an ethyl pyruvate bioisoster, exert robust neuroprotective effects in the postischemic brain.
Lee HK; Kim ID; Kim SW; Lee H; Park JY; Yoon SH; Lee JK
Sci Rep; 2017 Feb; 7():42891. PubMed ID: 28220827
[TBL] [Abstract][Full Text] [Related]
5. Combination treatment with ethyl pyruvate and aspirin enhances neuroprotection in the postischemic brain.
Kim SW; Jeong JY; Kim HJ; Seo JS; Han PL; Yoon SH; Lee JK
Neurotox Res; 2010 Jan; 17(1):39-49. PubMed ID: 19636661
[TBL] [Abstract][Full Text] [Related]
6. Glycyrrhizic acid affords robust neuroprotection in the postischemic brain via anti-inflammatory effect by inhibiting HMGB1 phosphorylation and secretion.
Kim SW; Jin Y; Shin JH; Kim ID; Lee HK; Park S; Han PL; Lee JK
Neurobiol Dis; 2012 Apr; 46(1):147-56. PubMed ID: 22266336
[TBL] [Abstract][Full Text] [Related]
7. Robust protective effects of a novel multimodal neuroprotectant oxopropanoyloxy benzoic acid (a salicylic acid/pyruvate ester) in the postischemic brain.
Kim SW; Kim HJ; Shin JH; Kim ID; Lee JE; Han PL; Yoon SH; Lee JK
Mol Pharmacol; 2011 Feb; 79(2):220-8. PubMed ID: 21036874
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of triflusal and its main metabolite in rats and dogs.
Ramis J; Mis R; Forn J
Eur J Drug Metab Pharmacokinet; 1991; 16(4):261-8. PubMed ID: 1823869
[TBL] [Abstract][Full Text] [Related]
9. Intranasal Delivery of RGD Motif-Containing Osteopontin Icosamer Confers Neuroprotection in the Postischemic Brain via αvβ3 Integrin Binding.
Jin YC; Lee H; Kim SW; Kim ID; Lee HK; Lee Y; Han PL; Lee JK
Mol Neurobiol; 2016 Oct; 53(8):5652-63. PubMed ID: 26482372
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of triflusal and its main metabolite HTB in an in vitro model of anoxia-reoxygenation in rat brain slices: comparison with acetylsalicylic and salicylic acids.
González-Correa JA; Arrebola MM; Ureña IM; Ruiz-Villafranca D; Muñoz-Marín J; Guerrero A; Sánchez de la Cuesta F; De La Cruz JP
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan; 371(1):81-8. PubMed ID: 15602657
[TBL] [Abstract][Full Text] [Related]
11. Intranasal delivery of HMGB1-binding heptamer peptide confers a robust neuroprotection in the postischemic brain.
Kim ID; Shin JH; Lee HK; Jin YC; Lee JK
Neurosci Lett; 2012 Sep; 525(2):179-83. PubMed ID: 22877697
[TBL] [Abstract][Full Text] [Related]
12. Anti-Inflammatory and Neuroprotective Effects of DIPOPA (N,N-Diisopropyl-2-Oxopropanamide), an Ethyl Pyruvate Bioisoster, in the Postischemic Brain.
Lee HK; Park JY; Lee H; Kim ID; Kim SW; Yoon SH; Lee JK
Neurotherapeutics; 2019 Apr; 16(2):523-537. PubMed ID: 30680637
[TBL] [Abstract][Full Text] [Related]
13. The histone deacetylase inhibitor, sodium butyrate, exhibits neuroprotective effects for ischemic stroke in middle-aged female rats.
Park MJ; Sohrabji F
J Neuroinflammation; 2016 Dec; 13(1):300. PubMed ID: 27905989
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the cerebral ischemic injury by ethyl pyruvate with a wide therapeutic window.
Yu YM; Kim JB; Lee KW; Kim SY; Han PL; Lee JK
Stroke; 2005 Oct; 36(10):2238-43. PubMed ID: 16141417
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic neuroprotective effects of XQ-1H in a rat model of permanent focal cerebral ischemia.
Yang Q; Fang W; Lv P; Geng X; Li Y; Sha L
Pharmacology; 2012; 89(1-2):1-6. PubMed ID: 22178991
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective potential of the group III mGlu receptor agonist ACPT-I in animal models of ischemic stroke: In vitro and in vivo studies.
Domin H; Przykaza Ł; Jantas D; Kozniewska E; Boguszewski PM; Śmiałowska M
Neuropharmacology; 2016 Mar; 102():276-94. PubMed ID: 26647070
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotection by biodegradable PAMAM ester (e-PAM-R)-mediated HMGB1 siRNA delivery in primary cortical cultures and in the postischemic brain.
Kim ID; Lim CM; Kim JB; Nam HY; Nam K; Kim SW; Park JS; Lee JK
J Control Release; 2010 Mar; 142(3):422-30. PubMed ID: 19944723
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotection, learning and memory improvement of a standardized extract from Renshen Shouwu against neuronal injury and vascular dementia in rats with brain ischemia.
Wan L; Cheng Y; Luo Z; Guo H; Zhao W; Gu Q; Yang X; Xu J; Bei W; Guo J
J Ethnopharmacol; 2015 May; 165():118-26. PubMed ID: 25704930
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective profile of novel SRC kinase inhibitors in rodent models of cerebral ischemia.
Liang S; Pong K; Gonzales C; Chen Y; Ling HP; Mark RJ; Boschelli F; Boschelli DH; Ye F; Barrios Sosa AC; Mansour TS; Frost P; Wood A; Pangalos MN; Zaleska MM
J Pharmacol Exp Ther; 2009 Dec; 331(3):827-35. PubMed ID: 19741150
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of a postischemic treatment with a bradykinin B2 receptor antagonist in a rat model of temporary focal cerebral ischemia.
Lumenta DB; Plesnila N; Kläsner B; Baethmann A; Pruneau D; Schmid-Elsaesser R; Zausinger S
Brain Res; 2006 Jan; 1069(1):227-34. PubMed ID: 16378603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
